Literature DB >> 6931260

Carcinogenicity of nitrosotrialkylureas in Fischer 344 rats.

W Lijinsky, M D Reuber, B N Blackwell.   

Abstract

Three nitrosotrialkylureas were administered to female F344 rats as approximately 1-mM solutions in drinking water. Nitrosotrimethylurea, given for 47 weeks, gave rise to astrocytomas of the brain and tumors of the forestomach; nitrosotriethylurea induced a high incidence of adenocarcinomas of the breast and uterus and tumors of the forestomach. Nitrosomethyldiethylurea induced almost exclusively a high incidence of both astrocytomas of the brain and tumors of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6931260

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

Review 1.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat.

Authors:  Niangoran Koissi; Niti H Shah; Brandon Ginevan; William S Eck; Bill D Roebuck; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2012-04-12       Impact factor: 3.739

Review 3.  Deuterium isotope effects in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Species differences in nitrosamine carcinogenesis.

Authors:  W Lijinsky
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

5.  High-yield induction of uterine endometrial adenocarcinomas in Donryu rats by a single intra-uterine administration of N-ethyl-N'-nitro-N-nitrosoguanidine via the vagina.

Authors:  J Ando-Lu; M Takahashi; S Imai; R Ishihara; T Kitamura; T Iijima; S Takano; K Nishiyama; K Suzuki; A Maekawa
Journal:  Jpn J Cancer Res       Date:  1994-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.